Sen, Malabika
Johnston, Paul A.
Pollock, Netanya I.
DeGrave, Kara
Joyce, Sonali C.
Freilino, Maria L.
Hua, Yun
Camarco, Daniel P.
Close, David A.
Huryn, Donna M.
Wipf, Peter
Grandis, Jennifer R.
Funding for this research was provided by:
National Cancer Institute
American Cancer Society
Article History
Received: 26 October 2016
Accepted: 6 April 2017
First Online: 11 May 2017
Compliance with ethical standards
:
: This project has been funded in part with Federal Funds from the National Cancer Institute, National Institutes of Health, under Contract No. HSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government. This study was supported by NExT-CBC Project ID #1015, S08-221 Task Order 6 “STAT3 Pathway Inhibitor HCS” (Grandis, PI), NCI Chemical Biology Consortium, Pittsburgh Specialized Application Center (PSAC) (Lazo and Johnston co-PIs), and University of Pittsburgh Chemical Diversity Center (Huryn, PI). The project was also supported in part by funds from the American Cancer Society (Grandis) and a Head and Neck Spore P50 award (Grandis, CA097190).